# Taxotere New Indication - Gastric Cancer Treatment Registration Trial

> **NCT00811447** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 243 (actual)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** 5-fluorouracil
- **DRUG:** Cisplatin
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT00811447
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 243 (ACTUAL)
- **Last updated:** 2012-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00811447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00811447, "Taxotere New Indication - Gastric Cancer Treatment Registration Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00811447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*